UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 817

Sortiert nach

Highly precise measurement of HIV DNA by droplet digital PCR

PloS one, 2013-04, Vol.8 (4), p.e55943-e55943

2013

Link zum Volltext

Verfügbarkeit prüfen

Antiviral Drug Discovery To Address the COVID-19 Pandemic

mBio, 2020-09, Vol.11 (5)

2020

Link zum Volltext

Verfügbarkeit prüfen

HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy

Nature medicine, 2017-05, Vol.23 (5), p.638-643

2017

Link zum Volltext

Verfügbarkeit prüfen

Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

The Lancet (British edition), 2013-06, Vol.381 (9883), p.2109-2117

2013

Link zum Volltext

Verfügbarkeit prüfen

Rates of emergence of HIV drug resistance in resource―limited settings: a systematic review

Antiviral therapy, 2013-01, Vol.18 (1), p.115-123

2013

Link zum Volltext

Verfügbarkeit prüfen

Challenge of Finding a Cure for HIV Infection

Science (American Association for the Advancement of Science), 2009-03, Vol.323 (5919), p.1304-1307

2009

Link zum Volltext

Verfügbarkeit prüfen

Minority Variants of Drug-Resistant HIV

The Journal of infectious diseases, 2010-09, Vol.202 (5), p.657-666

2010

Link zum Volltext

Verfügbarkeit prüfen

Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel

Clinical infectious diseases, 2008-07, Vol.47 (2), p.266-285

2008

Link zum Volltext

Verfügbarkeit prüfen

Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study

PLoS medicine, 2020-02, Vol.17 (2), p.e1003037-e1003037

2020

Link zum Volltext

Verfügbarkeit prüfen

HIV Type 1 (HIV-1) Proviral Reservoirs Decay Continuously Under Sustained Virologic Control in HIV-1-Infected Children Who Received Early Treatment

The Journal of infectious diseases, 2014-11, Vol.210 (10), p.1529-1538

2014

Link zum Volltext

Verfügbarkeit prüfen

Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection

PLoS pathogens, 2014-07, Vol.10 (7), p.e1004281

2014

Link zum Volltext

Verfügbarkeit prüfen

Temporal variation in HIV-specific IgG subclass antibodies during acute infection differentiates spontaneous controllers from chronic progressors

AIDS (London), 2018-02, Vol.32 (4), p.443-450

2018

Link zum Volltext

Verfügbarkeit prüfen

CD4+ and CD8+ T cell activation are associated with HIV DNA in resting CD4+ T cells

PloS one, 2014-10, Vol.9 (10), p.e110731-e110731

2014

Link zum Volltext

Verfügbarkeit prüfen

Rapid Evolution of the Neutralizing Antibody Response to HIV Type 1 Infection

Proceedings of the National Academy of Sciences - PNAS, 2003-04, Vol.100 (7), p.4144-4149

2003

Link zum Volltext

Verfügbarkeit prüfen

A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals

EBioMedicine, 2015-08, Vol.2 (8), p.874-883

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical Virology

Fourth edition, 2016

Link zum Volltext

Verfügbarkeit prüfen

Virologic Monitoring of Hepatitis B Virus Therapy in Clinical Trials and Practice: Recommendations for a Standardized Approach

Gastroenterology (New York, N.Y. 1943), 2008-02, Vol.134 (2), p.405-415

2008

Link zum Volltext

Verfügbarkeit prüfen

Disregarding drug resistance mutations without peril

AIDS (London), 2021-06, Vol.35 (7), p.1135-1136

Richman, Douglas D

2021

Link zum Volltext

Verfügbarkeit prüfen

Persistence of Transmitted Drug Resistance among Subjects with Primary Human Immunodeficiency Virus Infection

Journal of Virology, 2008-06, Vol.82 (11), p.5510-5518

2008

Link zum Volltext

Verfügbarkeit prüfen

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

The Lancet (British edition), 2005-08, Vol.366 (9485), p.549-555

2005

Link zum Volltext

Verfügbarkeit prüfen

Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy

PloS one, 2016-08, Vol.11 (8), p.e0160192-e0160192

2016

Link zum Volltext

Verfügbarkeit prüfen

Measuring the latent reservoir in vivo

The Journal of clinical investigation, 2016-02, Vol.126 (2), p.464-472

2016

Link zum Volltext

Verfügbarkeit prüfen

The prevalence of antiretroviral drug resistance in the United States

AIDS (London), 2004-07, Vol.18 (10), p.1393-1401

2004

Link zum Volltext

Verfügbarkeit prüfen

Detection of Minority Resistance during Early HIV-1 Infection: Natural Variation and Spurious Detection rather than Transmission and Evolution of Multiple Viral Variants

Journal of Virology, 2011-08, Vol.85 (16), p.8359-8367

2011

Link zum Volltext

Verfügbarkeit prüfen

Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model

PLoS pathogens, 2016-11, Vol.12 (11), p.e1006026-e1006026

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 817

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(646)
Mit Volltextzugriff
(686)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Highly precise measurement of HIV DNA by droplet digital PCR

Antiviral Drug Discovery To Address the COVID-19 Pandemic

HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy

Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

Rates of emergence of HIV drug resistance in resource―limited settings: a systematic review

Challenge of Finding a Cure for HIV Infection

Minority Variants of Drug-Resistant HIV

Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel

Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study

HIV Type 1 (HIV-1) Proviral Reservoirs Decay Continuously Under Sustained Virologic Control in HIV-1-Infected Children Who Received Early Treatment

Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection

Temporal variation in HIV-specific IgG subclass antibodies during acute infection differentiates spontaneous controllers from chronic progressors

CD4+ and CD8+ T cell activation are associated with HIV DNA in resting CD4+ T cells

Rapid Evolution of the Neutralizing Antibody Response to HIV Type 1 Infection

A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals

Clinical Virology

Virologic Monitoring of Hepatitis B Virus Therapy in Clinical Trials and Practice: Recommendations for a Standardized Approach

Disregarding drug resistance mutations without peril

Persistence of Transmitted Drug Resistance among Subjects with Primary Human Immunodeficiency Virus Infection

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy

Measuring the latent reservoir in vivo

The prevalence of antiretroviral drug resistance in the United States

Detection of Minority Resistance during Early HIV-1 Infection: Natural Variation and Spurious Detection rather than Transmission and Evolution of Multiple Viral Variants

Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model

Suchergebnisse filtern